Micro Pharma Agent Handbook
  • Introduction
    • Welcome Agents!
    • Purpose of the Program
    • Handbook Overview
  • Agent Certification
    • Certification Requirements
    • Agent Responsibilities and Code of Conduct
    • Benefits of Certification
  • Regulatory Overview
    • FDA Updates as of 2024
    • FDA Peptide Classifications (Category 1 & 2)
    • DEA & USADA Regulations
  • Product Knowledge
    • What are Peptides?
    • MicroPharma.us Catalog
    • Sourcing and Quality Control: ISO-Certified Labs
    • How to Manage your Ecwid Store
  • Sales and Marketing Guidelines
    • Peptide Sales Kit
      • Sales Pitches for Doctors
      • Common Questions and Answers
      • What to Say and Not Say (Legal Phrasing)
    • Handling Objections
    • Doctor Liability Waiver
  • Legal and Compliance Training
    • Understanding "For Research Purposes Only"
    • Avoiding Health Claims and Dosage Recommendations
    • Compliance with FDA, DEA, and USADA
  • Sub-Agent and Affiliate Program
    • Sub-Agent Certification Process
    • Managing Sub Agents and Commissions
  • Support
    • Ecwid Store Support
    • Contacting MicroPharma
Powered by GitBook
On this page
  1. Legal and Compliance Training

Avoiding Health Claims and Dosage Recommendations

As an agent, it's crucial to navigate the regulatory gray area when discussing peptides with potential clients, particularly when addressing health benefits or dosage suggestions. Making direct claims about peptides’ effects or recommending dosages can violate FDA regulations, as our products are labeled for research purposes only. However, there are ways to speak about peptides that stay within legal boundaries while still providing useful information.

Tips and Phrasing to Avoid Health Claims

When discussing peptides, it’s important to structure your statements to avoid making direct health claims. Here are a few approaches that agents can use to walk around making direct claims:

  1. Frame Statements in a Research Context: Instead of stating that a peptide is effective for a specific health condition, rephrase by mentioning how it is studied in research:

    • Example: “In research settings, peptides like BPC-157 have been studied for their potential effects on tissue regeneration and inflammation management.”

    • Why This Works: You are acknowledging what has been studied without suggesting its use for therapeutic purposes. This reinforces the research-only nature of the product without straying into making health claims.

  2. Use Examples from Clinical Trials or Published Studies: Citing clinical trials or published research provides credibility while keeping the conversation within a legal framework.

    • Example: “Some researchers have studied CJC-1295 in clinical trials to observe its impact on growth hormone release. The dosages used in these studies ranged from X to Z.”

    • Why This Works: By referencing legitimate research, you provide useful information without directly recommending the peptide for personal or clinical use.

  3. Focus on the Research Findings, Not Recommendations: Instead of stating what a peptide can do, emphasize what has been found in scientific studies:

    • Example: “In clinical studies, researchers found that TB-500 has been associated with enhanced tissue healing and reduced inflammation.”

    • Why This Works: You’re sharing valid research data without making personal health claims or recommendations.

Examples of Safe Phrasing

Here are some phrases that can help you stay compliant:

  • “In research settings, this peptide has been observed to...”

  • “Some researchers have studied this peptide’s effects on...”

  • “In clinical trials, the dosages were administered in the range of X to Z.”

  • “According to a study published in [journal], this peptide was used to investigate XYZ effects.”

By sticking to this language, you ensure that you’re not suggesting medical or personal use, but instead referencing what is already out in the research world.

PreviousUnderstanding "For Research Purposes Only"NextCompliance with FDA, DEA, and USADA

Last updated 7 months ago